Latest Insider Transactions at Procter & Gamble CO (PG)
This section provides a real-time view of insider transactions for Procter & Gamble CO (PG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROCTER & GAMBLE Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROCTER & GAMBLE Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2020
|
Steven D Bishop CEO - Health Care |
BUY
Exercise of conversion of derivative security
|
Direct |
72
+0.12%
|
$9,792
$136.85 P/Share
|
|
Dec 15
2020
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
97
-0.21%
|
$13,192
$136.85 P/Share
|
|
Dec 15
2020
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
63
+0.27%
|
$8,568
$136.85 P/Share
|
|
Dec 15
2020
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Payment of exercise price or tax liability
|
Direct |
33
-0.18%
|
$4,488
$136.85 P/Share
|
|
Dec 15
2020
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
BUY
Exercise of conversion of derivative security
|
Direct |
33
+0.18%
|
$4,488
$136.85 P/Share
|
|
Dec 15
2020
|
Marc S. Pritchard Chief Brand Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
87
-0.07%
|
$11,832
$136.85 P/Share
|
|
Dec 15
2020
|
Marc S. Pritchard Chief Brand Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
87
+0.07%
|
$11,832
$136.85 P/Share
|
|
Dec 15
2020
|
Moses Victor Javier Aguilar Chf Rsch, Dev & Innov Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16
-0.2%
|
$2,176
$136.85 P/Share
|
|
Dec 15
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Payment of exercise price or tax liability
|
Direct |
581
-0.29%
|
$79,016
$136.85 P/Share
|
|
Dec 15
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
BUY
Exercise of conversion of derivative security
|
Direct |
63
+0.06%
|
$8,568
$136.85 P/Share
|
|
Dec 15
2020
|
Shailesh Jejurikar Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
50
-15.82%
|
$6,800
$136.85 P/Share
|
|
Dec 15
2020
|
Shailesh Jejurikar Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50
+13.62%
|
$6,800
$136.85 P/Share
|
|
Dec 08
2020
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
254
+0.55%
|
-
|
|
Dec 08
2020
|
W James Mcnerney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
290
+0.34%
|
-
|
|
Dec 08
2020
|
Christine M Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
218
+5.11%
|
-
|
|
Dec 08
2020
|
Patricia A Woertz Director |
BUY
Grant, award, or other acquisition
|
Direct |
272
+0.74%
|
-
|
|
Dec 08
2020
|
Francis S Blake Director |
BUY
Grant, award, or other acquisition
|
Direct |
218
+1.12%
|
-
|
|
Dec 08
2020
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
263
+0.9%
|
-
|
|
Dec 08
2020
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
254
+1.18%
|
-
|
|
Dec 04
2020
|
Gary A Coombe CEO - Grooming |
SELL
Bona fide gift
|
Direct |
183
-1.99%
|
-
|
|
Dec 04
2020
|
Shailesh Jejurikar Chief Operating Officer |
SELL
Bona fide gift
|
Indirect |
130
-1.25%
|
-
|
|
Nov 30
2020
|
Peltz Nelson Director |
SELL
Open market or private sale
|
Indirect |
306,567
-1.52%
|
$41,999,679
$137.69 P/Share
|
|
Nov 19
2020
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
SELL
Discretionary transaction
|
Indirect |
26
-100.0%
|
$3,614
$139.18 P/Share
|
|
Nov 19
2020
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
BUY
Other acquisition or disposition
|
Indirect |
5
+16.13%
|
$695
$139.18 P/Share
|
|
Nov 13
2020
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
30,000
-9.94%
|
$4,320,000
$144.26 P/Share
|
|
Nov 13
2020
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.04%
|
$2,550,000
$85.13 P/Share
|
|
Nov 12
2020
|
Carolyn M Tastad CEO - Health Care |
SELL
Bona fide gift
|
Direct |
700
-1.37%
|
-
|
|
Nov 10
2020
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
SELL
Open market or private sale
|
Direct |
34,513
-40.09%
|
$4,831,820
$140.0 P/Share
|
|
Nov 10
2020
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34,513
+28.11%
|
$2,657,501
$77.62 P/Share
|
|
Nov 06
2020
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
35,000
-11.4%
|
$5,005,000
$143.31 P/Share
|
|
Nov 06
2020
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+10.24%
|
$2,975,000
$85.13 P/Share
|
|
Nov 03
2020
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
30,000
-9.94%
|
$4,260,000
$142.44 P/Share
|
|
Nov 03
2020
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+9.04%
|
$2,490,000
$83.87 P/Share
|
|
Nov 03
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Open market or private sale
|
Direct |
23,779
-32.06%
|
$3,376,618
$142.0 P/Share
|
|
Oct 27
2020
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
51,867
-33.51%
|
$7,365,114
$142.94 P/Share
|
|
Oct 27
2020
|
Carolyn M Tastad CEO - Health Care |
BUY
Exercise of conversion of derivative security
|
Direct |
51,867
+25.03%
|
$3,941,892
$76.66 P/Share
|
|
Oct 23
2020
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
35,054
-11.42%
|
$4,977,668
$142.67 P/Share
|
|
Oct 23
2020
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
35,054
+10.25%
|
$2,909,482
$83.87 P/Share
|
|
Oct 22
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Open market or private sale
|
Direct |
71,391
-49.05%
|
$10,066,131
$141.42 P/Share
|
|
Oct 22
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
BUY
Exercise of conversion of derivative security
|
Direct |
95,170
+39.53%
|
$7,232,920
$76.18 P/Share
|
|
Oct 21
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
79,380
-35.27%
|
$11,351,340
$143.75 P/Share
|
|
Oct 21
2020
|
R. Alexandra Keith CEO - Beauty |
BUY
Exercise of conversion of derivative security
|
Direct |
79,380
+26.04%
|
$6,747,300
$85.5 P/Share
|
|
Oct 21
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Indirect |
19,863
-39.74%
|
$2,860,272
$144.0 P/Share
|
|
Oct 21
2020
|
R. Alexandra Keith CEO - Beauty |
BUY
Exercise of conversion of derivative security
|
Indirect |
19,863
+28.41%
|
$1,688,355
$85.5 P/Share
|
|
Oct 13
2020
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+6.21%
|
-
|
|
Oct 13
2020
|
Debra L Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+50.0%
|
-
|
|
Oct 13
2020
|
Amy Chang Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+15.8%
|
-
|
|
Oct 13
2020
|
Francis S Blake Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+6.81%
|
-
|
|
Oct 13
2020
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+2.97%
|
-
|
|
Oct 13
2020
|
Margaret C Whitman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,387
+5.47%
|
-
|